학술논문

Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non-ST-segment-elevation Acute Coronary Syndrome: results from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute Coronary Syndrome-thrombolysis in Myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial
Document Type
Clinical report
Source
Circulation. Oct 9, 2007, Vol. 116 Issue 15, p1647, 6 p.
Subject
Heart attack -- Research
Ranolazine -- Physiological aspects
Ranolazine -- Research
Arrhythmia -- Drug therapy
Arrhythmia -- Diagnosis
Coronary thrombosis -- Care and treatment
Myocardial ischemia -- Research
Language
English
ISSN
0009-7322